NCT06505382View on ClinicalTrials.gov

Effects of Percutaneous Neuromouldation of the Saphenous Nerve in Patients With Patellofemoral Pain

NANot yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

June 30, 2025

Conditions
Patellofemoral Pain
Interventions
DIAGNOSTIC_TEST

Ultrasound-guided percutaneous neuromodulation

Percutaneous ultrasound-guided neuromodulation of the saphenous nerve in subjects with patellofemoral pain to assess its positive effects on pain and functionality.

Trial Locations (1)

28801

Campus Cientifico-Tecnologico UAH.Colegio de León c/ Libreros, 21, Alcalá de Henares

All Listed Sponsors
lead

University of Alcala

OTHER

NCT06505382 - Effects of Percutaneous Neuromouldation of the Saphenous Nerve in Patients With Patellofemoral Pain | Biotech Hunter | Biotech Hunter